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Cancer is one of the major health problems in the Kingdom of Bahrain. It is the second leading cause of death, after cardiovascular diseases, aca
counting for 12% of annually reported deaths.1 It inflicts 
a substantial burden on healthcare services, consuming 
a large proportion of financial and other resources.1 
The role of cancer registries in cancer control is 
not equivocal.2 Recognizing this important role, the 
Ministry of Health (MOH) put cancer control among 
its highest priorities and established a cancer registry. 
The establishment of the Bahrain Cancer Registry 
(BCR) through a ministerial decree (No. 5, 1994) was 
a key step in declaring cancer as a notifiable disease and 
laying the foundation for a database. This paper presa
ents the first 5 years experience of the newly established 
registry. It describes the epidemiological patterns of 
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BACKGROUND: cancer is the second leading cause of death, following cardiovascular diseases, accounting 
for 12% of annually reported deaths in bahrain. We determined the epidemiological patterns of malignancies in 
bahrain and compared them with those of other Gulf cooperation council (Gcc) countries and other developed 
countries.
SUBJECTS AND METHODS: data for the study were obtained from the bahrain cancer registry (bcr) data-
base. the overall and type-specific 5-year average incidence rates were calculated for the years 1998-2002 
and derived using the canreG software formula. the incidence rates for the year 2000 were used for compar-
ing bahrain with those of other countries in the arabian Gulf using the statistics of the Gulf centre for cancer 
registration.
RESULTS: during the 5-year period there were 2405 cancer cases in bahrain (1239 males and 1166 females), 
with an annual average of 481 cases. the world age-standardized incidence rates (asr) were 162.3 and 145.2 
per 100 000 for bahraini males and females, respectively. Generally, bahraini men had a higher asr for most 
cancer types, and the most common type of cancer| was lung for males (35.2 per 100 000), followed by bladder 
(14.5) and prostate (14.3), and breast for females (46.8), followed by lung (12.2) and ovary (7.7). 
CONCLUSION: compared to other Gulf countries, bahrain had higher incidence rates for cancers of the lung, 
prostate, colorectum, bladder, kidney, pancreas and leukemia among males and for cancers of the breast, lung, 
bladder, thyroid, uterus and ovary among females. a rising trend in cancer incidence is likely to continue for 
years or even decades to come.
malignancies in Bahrain and compares them with those 
of other Gulf Cooperation Council (GCC) countries 
and other developed countries. 
The Kingdom of Bahrain is located centrally on the 
southern shores of the Arabian Gulf, and comprises of 
an archipelago of islands with a total land area of 717.5 
square kilometers. Bahrain island is the largest of these 
islands accounting for nearly 83% of the total area of the 
Kingdom including the capital, Manama.3 According 
to the 2001 census, the total population of Bahrain 
was 650 604 persons of whom 405 667 (62.4%) were 
Bahraini and 244 937 nonaBahraini. The growth rate 
between the 1991 and the 2001 censuses was 2.7% for 
the total population, 2.5% for the Bahraini and 3.1% for 
the nonaBahraini.4 The 5ayear average estimated mida
year population for 1998a2002 was 638 033 of whom, 
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398 455 (62.5%) were Bahraini, and 239 578 (37.5%) 
were nonaBahraini.3 It should be noted here that the 
majority of the nonaBahraini population (69.2%) are 
males, who form the major part of the working force. 
The nonaBahraini population is unstable, characterized 
by a very rapid turn over during the year, and their trana
sitional nature could affect the interpretation of cancer 
occurrences.
The government is committed to providing a high 
standard of comprehensive health care to residents,5 ina
cluding public health, and primary, secondary and tertiaa
ry care services. Primary health care is delivered through 
a network of 22 wellaequipped health centers, staffed 
with qualified family physicians and allied health pera
sonnel and distributed in all geographic regions. General 
and specialized secondary care is provided through the 
main government hospital, Salmaniya Medical Complex 
(SMC), which has recently been expanded to house the 
new Oncology Services Centre that is equipped with 
the latest diagnostic and therapeutic technology to proa
vide different types of treatment including chemothera
apy, radiotherapy, immunotherapy and bone marrow 
transplantation.1 The Bahrain Defense Force (BDF) 
Hospital is the second general secondary hospital that 
primarily serves Ministry of Defense employees and 
their families and accommodates the centre for cardiac 
surgery in the country. Secondary care is also provided 
by six other private hospitals. Together, the government 
and private hospitals have a capacity of around 2000 
beds and ratios of 22 doctors of different specialties and 
50 nurses for every 10 000 population.1
SUBJECTS AND METHODS
The BCR is a populationabased registry where all phya
sicians in the Kingdom were requested in 1994, followa
ing the ministerial decree, to report all cancer cases to 
the Cancer Registry Office, which is organizationally 
annexed to the Medical Review Office at SMC. A fulla
time epidemiologist and a partatime medical records 
technician working as a tumor registrar operate the 
registry.
Cases included in the study were those registered 
as having a malignant disease in the BCR between 1 
January 1998 and 31 December 2002, whether the 
cancer was microscopically or clinically diagnosed. 
Personal, clinical and tumor details are entered in the 
registry using a specially designed registration form, 
and checked for duplication and consistency using the 
CANREG IV software that was developed by The 
International Agency for Research on Cancer (IARC) 
specifically for cancer registration.6 Coding anatomical 
sites and morphology of tumors is done according to the 
International Classification of Diseases for Oncology 
(ICDaOa3).7 
In addition to passive notification, case finding is 
enhanced by several approaches. First, medical rea
cords of patients admitted with cancer to SMC, which 
is the main source of cases, are sorted at the Medical 
Record Department upon discharge and checked for 
their registration status. Second, the Registrar visits 
the BDF Hospital periodically to review and identify 
lists of newly diagnosed cases. Third, the Registrar also 
receives cancer death notifications from the Birth and 
Death Registration Office, MOH, on a regular basis. 
The “Death Certificate Notification” (DCN) cases are 
crossamatched with the registered cases to sort out the 
unmatched cases (true DCN), which are then followed 
back for any hospital information related to malignancy 
and date of diagnosis. Of these true DCN cases, any 
case would be registered as an ordinary one if there 
were enough information indicating that it was an incia
dent case. Those with insufficient clinical data or if the 
information was not indicative of the cancer are regisa
tered as “Death Certificate Only” (DCO) cases.
Using the check program, which is builtain within 
the CANREG software, data were examined for duplia
cate registration as well as for illogical errors in coma
binations of variables such as siteasex, siteamorphology 
and ageamorphology. Data was also checked for illogical 
combinations that could not be captured by CANREG 
such as morphology versus basis of diagnosis (e.g., leua
kemia), behavior versus stage codes (for inasitu), basis 
of diagnosis versus status codes (for DCO) and mora
phology versus stage. Cases in which diagnosis was 
based on the histology of metastasis (secondary site) 
were reviewed to ensure that the depicted site was for 
the suggested primary and not for the secondary tua
mor. Missing date of birth was replaced by the first 
two digits of the Central Population Register number, 
which represents the year of birth. In this case, the first 
of January was designated to complete the full date of 
birth. Missing data for unknown primary site and other 
variables were sought and recorded when found. 
Incidence rates were calculated from the CANREG 
software, in which crude total and ageasexaspecific incia
dence rates (ASPRs) for each type of cancer were cala
culated by dividing the number of registered cases in a 
year by the corresponding estimated midayear populaa
tion for the same year, the latter being an approximation 
of the personayears at risk.
The 5ayear average total and ASPRs for the period 
from 1998 to 2002 were calculated according to the 
method used in “Cancer Incidence in Five Continents”.8 
In this method, the total number of cases registered in 
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the 5ayear period is divided by person years at risk dea
rived by multiplying the midayear estimated population 
of the middle year (2000) times the number of years of 
the study period (five years). Rates were standardized 
for age and sex, by the direct standardization method 
using the world standard population supplied by the 
CANREG software. 
The ageastandardized incidence rates (ASRs) of 
some of the leading cancers in Bahrain in the year 2000 
were compared with the corresponding rates for the 
same year for Kuwait, Oman and Saudi Arabia.9 These 
countries were chosen because they have good national 
coverage and reliable cancer registries, and as data for 
the 5ayear period is not available for these countries, the 
year 2000 was taken to represent the midayear of the 
1998a2002 period.
RESULTS
Overall cancers
During the 5ayear period (1998a2002) there were 
2405 cancer cases in Bahrain (1239 males and 1166 
females) with an annual average of 481 cases. Of the 
males, 962 were Bahraini and 277 nonaBahraini. The 
corresponding figures for females were 964 and 202, 
respectively. The average annual crude incidence cana
cer rates for males were 95.7/100 000 among the 
Bahrainis, 33.4/100 000 among the nonaBahrainis, 
and 67.6/100 000 among all males combined. The cora
responding rates for females were 97.7, 54.7 and 86.0 
per 100 000 women, respectively. The world ASRs were 
162.3 and 145.2 per 100 000 among Bahraini males and 
Bahraini females, respectively. The corresponding rates 
for the nonaBahraini males and females were 116.3 and 
115.4 per 100 000, respectively, and the ASR for both 
Bahrainis and the nonaBahrainis were 147.7 and 139.1 
per 100 000, respectively. Generally, ASPRs increased 
with age for both Bahraini and nonaBahraini males and 
females (Figure 1). Compared to males, females showed 
higher rates at young ages and lower rates at older ages 
among both Bahrainis and nonaBahrainis. 
Cancer among the Bahraini population
Bahraini males had higher ASRs than females in ala
most all common cancers except thyroid cancer (Table 
1). Bladder cancer was four times more common, cana
cer of the lung almost three times more common while 
colorectal and pancreatic cancers were two times more 
common among males than females. In contrast, thyroid 
cancer was almost seven times more common among fea
males than males.
Bronchial and lung cancer is the commonest cancer 
among Bahraini males, followed by bladder, prostate, 
colorectal cancers, and leukemia (Figure 2). The coma
monest five cancers among Bahraini females are breast, 
lung, thyroid, ovary and colorectal (Figure 3).
The ASPRs of the five commonest cancers among 
Bahraini males and females (Figures 4, 5) indicate large 
gaps between the leading cancer in each sex and other 
cancers at all age groups. Lung cancer among males 
increases steeply with age, particularly at the older 
ages. Breast cancer has a bimodal distribution among 
Bahraini females with the first mode between the mid 
40’s and the mid 50’s and the second at the 65a69 years 
age group. Prostate cancer has a pattern similar to that 
of lung cancer among males but with a delayed start. 
Table 1. Age-standardized rate (world)/100 000 for common cancers among Bahraini 
males and females, 1998-2002. 
Cancer type Male Female M/F
Trachea, bronchus and lung (C33-34) 35.2 12.2 2.9:1
Colorectal (C18-20) 12.8 7.3 1.8:1
Leukemia (C91-95) 9.1 4.4 2.1:1
Bladder (C67) 14.5 3.8 4.4:1
Non-Hogdkin’s lymphoma (C82-85;96) 7.9 5.8 1.4:1
Stomach (C16) 8.7 5.4 1.6:1
Thyroid (C73) 1.1 7.6 1:6.9
Kidney (C64-66;C68) 5.2 3.5 1.4:1
Liver (C22) 5.2 3.5 1.5:1
Pancreas (C25) 4.9 2.8 1.8:1
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Figure 1. Average age-specific incidence rates of all cancers by nationality and gender, 
1998-2002
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Figure 2. Incidence rates of commonest types of cancer among Bahraini males, 1998-2002.
Figure 3. Incidence rates of commonest types of cancer among Bahraini females, 1998-2002.
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Bladder cancer directly increases with age after the 
age of 40 years among males. In males, leukemia has a 
similar pattern as that of prostate cancer but with lower 
rates at all age groups. Colorectal cancer in males has a 
peak in the 70a74 years age group. Lung cancer among 
Bahraini females has an identical age pattern as that of 
the males with lower rates at all age groups. Colorectal 
cancer among females has a slow and gradual increase 
with a peak at the age 55a59 years and higher rates from 
65 years and above. The ASPRs of colorectal cancers 
among females are lower than their male counterparts. 
Ovarian cancer has a bimodal distribution with age 
while thyroid cancer is unimodal with its highest peak 
at the age of 60a64 years.
Comparing of the sexaspecific cancers among the 
Bahraini with their counterparts in GCC countries 
population, Bahraini females have the highest incia
dence rates of breast, uterus and ovarian cancers and 
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the second for cervical cancer among GCC countries, 
and Bahraini males have the highest ASR for prostate 
cancer in the year 2000 (Tables 2, 3). The ASR for 
breast cancer among Bahraini females in that year was 
57.2 per 100 000. The corresponding rates for Kuwaiti, 
Omani and Saudi females were 41.7, 14.9 and 13.9 per 
100 000, respectively. The ASRs for ovarian and endoa
metrial cancers among Bahraini females were 8.2 and 5.5 
per 100 000, respectively. The corresponding rates were 
4.3, and 3.0 for Kuwaiti, and 6.0, 1.3 for Omani, and 
2.2 and 2.4 per 100 000 for Saudi females, respectively. 
Bahrain ranks second to Oman in cancer of the cervix, 
the rate being 4.4 per 100 000 in 2000 for the Bahraini 
and 7.0 per 100 000 for the Omani females. The rates 
for Kuwaiti and Saudi females in 2000 were 2.3 and 2.1 
per 100 000, respectively (Table 2). The ASR for cana
cer of the prostate among Bahraini males was 19.3 per 
100 000 in 2000. The corresponding rates in the same 
year were 7.3, 8.7 and 3.6 per 100 000 among Kuwaiti, 
Omani and Saudi males (Table 3).
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Figure 4. Age-specific incidence rates of five commonest cancers among Bahraini males, 1998-2002.
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Figure 5. Age-specific incidence rates of five commonest cancers among Bahraini females, 1998-2002.
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Cancer of the lung was highest in the Bahraini coma
pared to their Kuwaiti, Omani and Saudi counterparts 
in that year. It was 8 times more common in Bahraini 
than Saudi males and nearly 10 times more common 
among the Bahraini than the Saudi females. Bahrain 
had the highest rates of bladder cancer in both sexes 
compared to the other GCC countries. The male rates 
were 3.9 times higher in the Bahraini compared to the 
Saudi, 4 times compared to the Omani and 2.4 times 
compared to the Kuwaiti. The Bahraini female rates 
were 3.7 times that of the Saudi, 2.5 times that of the 
Omani and 2 times of the Kuwaiti female rates for blada
der cancer. Bahraini females had the highest incidence 
rate of thyroid cancer in the GCC countries while the 
Bahraini males had a very slightly higher ASR. Bahraini 
males had also the highest rates of colorectal, kidney, 
liver and pancreatic cancers. Moreover, the Bahraini fea
males had the highest ASRs in GCC countries for cana
cers of the stomach, kidney, liver and pancreas. Bahraini 
males were second for stomach cancer while females oca
cupied the same rank for colorectal cancer and leukemia 
(Tables 2, 3). 
DISCUSSION
Before any interpretation of the findings can be made, 
completeness of registration and the quality of the data 
need to be addressed. It is known that in their early 
stages registries face a problem of incompleteness, which 
improves when more vigilant quality control measures 
are applied and the awareness of notifying physicians 
of the existence and benefits of the registry increases.10 
Cancer registration in Bahrain started in 1994 and, as 
with any newly established registry, there were some difa
ficulties in ascertaining all cases and gathering all the 
required information as well as in coding and validaa
tion procedures. From 1998 onward, registration was 
done following a set of rules described in the manual 
of registration of the World Health Organization11 and 
checking the data through CANREG software. As for 
the coverage, in the years prior to 1998, registered cases 
were those reported from the SMC, the only hospital 
that provided oncology care and radioa and chemoa
therapy in the country. Coverage is considered good 
as not less than three fourths of the cases in Bahrain 
are diagnosed at SMC. The cooperation with the BDF 
Hospital, since 1998, yielded better coverage, especially 
for cases that might be diagnosed and treated overseas. 
Moreover, coverage is further enhanced by the routine 
crossachecking of the BCR with the death register.
Taking into consideration possible artifacts in the 
currently presented incidence statistics of the disease, 
Bahrain is right in the heart of the third stage of trana
Table 2. Age-standardized rate (world)/100 000 for common cancers among Bahraini 
females and their counterparts in selected Gulf Cooperation Council countries, 2000.
Site (ICD-10) Bahrain Kuwait Oman Saudi
Breast (C50) 57.2 41.7 14.9 13.9
Trachea, bronchus and 
lung (C33-34) 12.3 2.7 2.0 1.3
Colorectal (C18-20) 9.0 14.7 4.4 4.5
Cervix uteri (C53) 4.4 2.3 7.0 2.1
Uterus (C54-55) 5.5 3 1.3 2.4
Ovary (C56) 8.2 4.3 6.0 2.2
Leukemia (C91-95) 2.6 2.5 4.1 3.1
Bladder (C67) 3.7 1.8 1.5 1.0
Non-Hogdkin’s 
lymphoma 
 (C82-85;C96)
5.1 3.5 5.4 3.9
Stomach (C16) 6.5 0.9 5.6 1.5
Thyroid (C73) 8.1 5.0 4.0 4.5
Kidney (C64-66;C68) 5.6 0.8 1.9 0.9
Liver (C22) 7.3 0.6 3.1 2.7
Pancreas (C25) 2.1 1.5 1.2 0.8
Table 3. Age-standardized rate (world)/100 000 for common cancers among Bahraini 
males and their counterparts in selected GCC Countries, 2000.
Site (ICD-10) Bahrain Kuwait Oman Saudi
Trachea, bronchus 
and lung (C33-34) 33.5 16.0 8.8 4.3
Prostate (C61) 19.3 7.3 8.7 3.6
Colorectal (C18-20) 12.5 10.2 4.1 4.7
Leukemia (C91-95) 7.1 2.8 5.9 3.4
Bladder (C67) 14.5 6.0 3.6 3.7
Non-Hogdkin’s 
lymphoma
(C82-85;C96)
5.6 10.1 7.7 5.3
Stomach (C16) 11.2 2.5 13.2 2.7
Thyroid (C73) 1.6 1.5 1.1 1.4
Kidney (C64-66;C68) 6.5 5.9 2.6 1.9
Liver (C22) 7.4 4.0 5.9 6.1
Pancreas (C25) 4.1 2.3 2.3 1.5
original research reportCANCER INCIDENCE IN BAHRAIN
Hematol Oncol Stem Cell Ther 1(3)     July 2008 hemoncstem.edmgr.com 181
sition, according to Omran’s theory of epidemiologic 
transition,12 where chronic diseases, namely those of 
the cardiovascular system, cancer and diabetes are doma
inating the main burden of disease. They account for 
more than half of reported annual deaths, with cancer 
occupying the second rank of leading causes of death 
following cardiovascular diseases.1 This is in line with 
lifestyle changes that have taken place in the Bahraini 
community in the last two decades. The prevalence 
of tobacco smoking is 25% in men and nearly 10% in 
women.13 In fact, the phenomenon of women smoking 
is increasing with the spread of sheesha (water pipe) 
smoking, and the increase in social acceptability of this 
type of smoking in the Kingdom.13 Moreover, obesity 
is on the increase with more than half of women and 
men either overweight or obese, and very few exercise 
regularly.14,15
The pattern of cancer incidence reported here for 
males is slightly different from that in the developed 
countries as lung cancer is the leading type among 
Bahraini men while prostate cancer has now taken the 
lead in many of developed countries.16 This could partly 
be due to the increased screening and early diagnosis, 
which intensified in the western world. For females, 
however, the patterns are similar with breast cancer 
by far the leading type. Breast cancer among Bahraini 
women (46.8/100 000) is four times that of lung cancer 
(12.2/100 000), the second commonest. One distinct 
observation in the incidence of breast cancer in Bahraini 
females compared to western countries, is that it begins 
to increase in incidence early in a young age group, a 
phenomenon which could warrant some genetic predisa
position that needs further study. The pattern of cancer 
in Bahraini males is different from that of other GCC 
countries. Lung cancer ranks first for Bahraini males 
in contrast to stomach cancer among the Omani, and 
leukemia among Saudi males. Breast cancer however, 
is the most frequent cancer in all females in the GCC 
countries.9
With the evolving lifestyle behaviors that lead to an 
increasing risk of cancer occurrence, along with cura
rently modest prevention and control activities, the pata
tern of common types of cancer in Bahrain is likely to 
pursue a rising trend for years or even decades to come. 
This situation is challenging to the health authorities in 
their attempts to ameliorate the cancer burden on the 
community. Moreover, in the current healthcare system 
the government ensures availability and accessibility of 
cancer preventive and curative services to all residents of 
the country, which imposes a huge financial burden on 
the MOH. However, the government has a great oppora
tunity to cut the cost by strengthening cancer prevena
tive programs since about sixty percent of the common 
cancers in Bahrain are associated with smoking and diet 
and thus are preventable.17 It is universally accepted that 
a more than 50% reduction in cancer mortality could be 
expected from effective antiatobacco programs (35%) 
and modification of dietary habits (20%) in developing 
countries.2,18 Furthermore, about a 20% reduction in 
breast cancer mortality is achievable through a properly 
designed and implemented screening program.2,19 A rea
cent systematic review of seven completed and eligible 
trials showed a similar overall reduction rate, but as the 
effect was lower in the highest quality trials, the authors 
concluded that a more reasonable estimate is a 15% 
relative risk reduction. Meanwhile, the authors warned 
of the possible harms of overadiagnosis and overatreata
ment that screening might cause.20 
These promising results in all such preventive moa
dalities are, however, not easy to achieve without the 
realization of the need for resources including orgaa
nizational, physical and human; and the sustainable 
commitment to procure them. We must also undera
stand that it is difficult to convince people to put their 
knowledge about healthy behaviors into practice. For 
example, antiatobacco measures may take up to thirty 
years before their maximum impact on cancer incidence 
is realized. For that, scientists believe that there will be 
a strong role for early detection and screening, treata
ment and palliative care modalities for years to come. 
They warn that screening is not just testing. It requires 
goodcompliance, a highaquality test, efficient referral, 
effective treatment and adequate follow up.19,21 Above 
all, the health authorities in Bahrain must invest heavily 
now in preventive cancer health care and not expect the 
payback until ten to twenty years from now.
This article is a reprint, originally published in the Annals of Saudi Medicine. 2007 Jul-Aug;27(4):251-8.
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